| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2000321 | 重组抗CD38全人单克隆抗体注射液 | Recombinant Anti-CD38 Humanized Monoclonal Antibody | Injection | Biological Products(3.3) | New Drug Application | 2020-11-12 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd | In Review | 2020-11-11 | view |